News
Kinder Morgan Is Doing Well, But Not Well Enough For An Upgrade
Kinder Morgan remains a 'hold' as upside appears limited despite strong operational performance and a $10B project backlog. KMI's Q1 2026 saw revenue up 13.8% and adjusted operating cash flow rise to
TransUnion Brings New Alternative Credit Signals to Mortgage Decisioning
Alternative Credit Attributes advance TransUnion's legacy of innovation with more comprehensive data for smarter mortgage decisions Alternative Credit Attributes advance TransUnion's legacy of innovat
ABB Ltd (ABB:CA) Q2 2026 Earnings Call Transcript
ABB Ltd (ABB:CA) Q2 2026 Earnings Call Transcript
The AI Supply Chain Just Confirmed Nvidia's Future
TSMC and ASML both raised guidance, confirming AI infrastructure remains supply constrained, while Rubin's N3 node is fully booked and CoWoS capacity expands nearly 50%. Nvidia's Kyber delay concerns
J.B. Hunt Q2: Hauling Record Shareholder Returns
J.B. Hunt reported Q2 results that exceeded expectations on both the top and bottom lines. The company also reported record quarterly volumes in its Intermodal business. Shares were already trading at
MDA SPACE TO HOLD ITS SECOND QUARTER 2026 EARNINGS CONFERENCE CALL ON AUGUST 7, 2026
TORONTO, July 16, 2026 /PRNewswire/ -- MDA Space Ltd. (TSX:MDA) (NYSE:MDA), a trusted mission partner to the rapidly expanding global space industry, will release its second quarter 2026 financial res
Zoomd Technologies Announces Grant of Options and RSUs
TORONTO, July 16, 2026 /PRNewswire/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd.
10.9% Run Up, But Still Undervalued: FactSet
FactSet Research Systems remains undervalued, trading at a 44% discount to a fair value estimate of $445 per share. FDS's AI-enhanced products are driving organic ASV growth (+7% in Q3 2026), with cli
ZG and Z SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Zillow Group (ZG, Z) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zillow To Contact Him Directly To Discuss Their Options If you purchased or acquired
Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide
Virtual-first, multidisciplinary care model delivers care for adults living with ataxias, connecting them to expert neurologist options nationwide. CHICAGO, July 16, 2026 /PRNewswire/ -- Synapticure,
PowerCell Sweden AB (publ) (PCELF) Q2 2026 Earnings Call Transcript
PowerCell Sweden AB (publ) (PCELF) Q2 2026 Earnings Call Transcript
GTM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ZoomInfo Investors of Securities Class Action Lawsuit Deadline on August 24, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ZoomInfo To Contact Him Directly To Discuss Their Options If you purchased or acquire
Graycliff Closes First Tranche of LIFE Financing
Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - Graycliff Exploration Limited (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) (the "Company" or "Graycliff") is pleased to announce it has closed the first
E1 Announces Sports.com Predict as Official Prediction Partner
FORT WORTH, Texas, July 16, 2026 (GLOBE NEWSWIRE) -- Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG, LTRYW) (“SEGG Media” or “the Company”) today announced that Sports.com Predict has be
MGN SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Megan Holdings Limited Investors of Securities Class Action Lawsuit Deadline on September 8, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Megan To Contact Him Directly To Discuss Their Options If you purchased or acquired s
Alternatives ETFs Punching Above Their Weight in 2026
Halfway through the year, the U.S. equity market performance is broadening. That said, market concentration remains incredibly high, while equity and bond correlations sit in positive territory — cond
Citi starts Hikma at 'buy' with strategy reset offering compelling entry point
Citi has initiated coverage of Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) with a 'buy' rating and a £17 price target, arguing the generic drugmaker's current valuation offers a compelling entry po
Xenon Pharmaceuticals: Azetukalner Has Shifted From Binary Science To Commercial Execution
Xenon Pharmaceuticals (XENE) is transitioning into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform and strong Phase 3 epilepsy data. XENE's lead candidate,
Tesla's Delivery Surprise Was Big—Earnings Need to Be Bigger
Tesla TodayTSLATesla$394.35 -1.83 (-0.46%) As of 07/15/2026 04:00 PM Eastern52-Week Range$297.82▼$498.83P/E Ratio361.79Price Target$408.07Add to WatchlistTesla Inc. NASDAQ: TSLA shares have been conso
FSLR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds First Solar (FSLR) Investors of Securities Class Action Lawsuit Deadline on August 24, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In First Solar To Contact Him Directly To Discuss Their Options If you purchased or acqu
